|
1
|
Grubbs EG, Rich TA, Li G, et al: Recent
advances in thyroid cancer. Curr Probl Surg. 45:156–250. 2008.
View Article : Google Scholar
|
|
2
|
Dal Maso L, Bosetti C, La Vecchia C and
Franceschi S: Risk factors for thyroid cancer: an epidemiological
review focused on nutritional factors. Cancer Causes Control.
20:75–86. 2009.PubMed/NCBI
|
|
3
|
Adjadj E, Schlumberger M and de Vathaire
F: Germ-line DNA polymorphisms and susceptibility to differentiated
thyroid cancer. Lancet Oncol. 10:181–190. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gudmundsson J, Sulem P, Gudbjartsson DF,
et al: Common variants on 9q22.33 and 14q13.3 predispose to thyroid
cancer in European populations. Nat Genet. 41:460–464. 2009.
View Article : Google Scholar
|
|
5
|
Sigurdson AJ, Hauptmann M, Alexander BH,
Doody MM, Thomas CB, Struewing JP and Jones IM: DNA damage among
thyroid cancer and multiple cancer cases, controls, and long-lived
individuals. Mutat Res. 586:173–188. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hoeijmakers JH: Genome maintenance
mechanisms for preventing cancer. Nature. 411:366–374. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ho T, Li G, Lu J, Zhao C, Wei Q and
Sturgis EM: Association of XRCC1 polymorphisms and risk of
differentiated thyroid carcinoma: a case-control analysis. Thyroid.
19:129–135. 2009.
|
|
8
|
Chiang FY, Wu CW, Hsiao PJ, et al:
Association between polymorphisms in DNA base excision repair genes
XRCC1, APE1, and ADPRT and differentiated
thyroid carcinoma. Clin Cancer Res. 14:5919–5924. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Akulevich NM, Saenko VA, Rogounovitch TI,
et al: Polymorphisms of DNA damage response genes in
radiation-related and sporadic papillary thyroid carcinoma. Endocr
Relat Cancer. 16:491–503. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Santos LS, Branco SC, Silva SN, et al:
Polymorphisms in base excision repair genes and thyroid cancer
risk. Oncol Rep. 28:1859–1868. 2012.PubMed/NCBI
|
|
11
|
Gomes BC, Silva SN, Azevedo AP, et al: The
role of common variants of non-homologous end-joining repair genes
XRCC4, LIG4 and Ku80 in thyroid cancer risk.
Oncol Rep. 24:1079–1085. 2010.PubMed/NCBI
|
|
12
|
Xu L, Doan PC, Wei Q, Liu Y, Li G and
Sturgis EM: Association of BRCA1 functional single
nucleotide polymorphisms with risk of differentiated thyroid
carcinoma. Thyroid. 22:35–43. 2012.
|
|
13
|
Bastos HN, Antão MR, Silva SN, et al:
Association of polymorphisms in genes of the homologous
recombination DNA repair pathway and thyroid cancer risk. Thyroid.
19:1067–1075. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Gatzidou E, Michailidi C,
Tseleni-Balafouta S and Theocharis S: An epitome of DNA repair
related genes and mechanisms in thyroid carcinoma. Cancer Lett.
290:139–147. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Silva SN, Gomes BC, Rueff J and Gaspar JF:
DNA repair perspectives in thyroid and breast cancer: the role of
DNA repair polymorphisms. DNA Repair and Human Health. Vengrova S:
InTech; pp. 459–484. 2011
|
|
16
|
Nouspikel T: DNA repair in mammalian
cells: nucleotide excision repair: variations on versatility. Cell
Mol Life Sci. 66:994–1009. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Silva SN, Gil OM, Oliveira VC, et al:
Association of polymorphisms in ERCC2 gene with non-familial
thyroid cancer risk. Cancer Epidemiol Biomarkers Prev.
14:2407–2412. 2005.PubMed/NCBI
|
|
18
|
Zhao H, Wang LE, Li D, Chamberlain RM,
Sturgis EM and Wei Q: Genotypes and haplotypes of ERCC1 and
ERCC2/XPD genes predict levels of benzo[α]pyrene diol
epoxide-induced DNA adducts in cultured primary lymphocytes from
healthy individuals: a genotype-phenotype correlation analysis.
Carcinogenesis. 29:1560–1566. 2008.
|
|
19
|
Yu T, Liu Y, Lu X, et al: Excision repair
of BPDE-adducts in human lymphocytes: diminished capacity
associated with ERCC1 C8092A (rs3212986) polymorphism. Arch
Toxicol. 87:699–709. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Pingarilho M, Oliveira NG, Martins C,
Fernandes AS, de Lima JP, Rueff J and Gaspar JF: Genetic
polymorphisms in detoxification and DNA repair genes and
susceptibility to glycidamide-induced DNA damage. J Toxicol Environ
Health A. 75:920–933. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lange K, Cantor R, Horvath S, Perola M,
Sabatti C, Sinsheimer J and Sobel E: Mendel version 4.0: a complete
package for the exact genetic analysis of discrete traits in
pedigree and population data sets. Am J Hum Genet.
69:A18862001.
|
|
22
|
Pan J, Lin J, Izzo JG, et al: Genetic
susceptibility to esophageal cancer: the role of the nucleotide
excision repair pathway. Carcinogenesis. 30:785–792. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wu X, Gu J, Grossman HB, et al: Bladder
cancer predisposition: a multigenic approach to DNA-repair and
cell-cycle-control genes. Am J Hum Genet. 78:464–479. 2006.
View Article : Google Scholar
|
|
24
|
Lin J, Pu X, Wang W, Matin S, Tannir NM,
Wood CG and Wu X: Case-control analysis of nucleotide excision
repair pathway and the risk of renal cell carcinoma.
Carcinogenesis. 29:2112–2119. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Enjuanes A, Benavente Y, Bosch F, et al:
Genetic variants in apoptosis and immunoregulation-related genes
are associated with risk of chronic lymphocytic leukemia. Cancer
Res. 68:10178–10186. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chen M, Kamat AM, Huang M, et al:
High-order interactions among genetic polymorphisms in nucleotide
excision repair pathway genes and smoking in modulating bladder
cancer risk. Carcinogenesis. 28:2160–2165. 2007. View Article : Google Scholar
|
|
27
|
Francisco G, Menezes PR, Eluf-Neto J and
Chammas R: XPC polymorphisms play a role in tissue-specific
carcinogenesis: a meta-analysis. Eur J Hum Genet. 16:724–734. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Qiu L and Wang Z, Shi X and Wang Z:
Associations between XPC polymorphisms and risk of cancers: a
meta-analysis. Eur J Cancer. 44:2241–2253. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
He J, Shi TY, Zhu ML, Wang MY, Li QX and
Wei QY: Associations of Lys939Gln and Ala499Val polymorphisms of
the XPC gene with cancer susceptibility: a meta-analysis.
Int J Cancer. Feb 7–2013.(Epub ahead of print). View Article : Google Scholar
|
|
30
|
Zhang D, Chen C, Fu X, et al: A
meta-analysis of DNA repair gene XPC polymorphisms and
cancer risk. J Hum Genet. 53:18–33. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Stern MC, Lin J, Figueroa JD, et al:
Polymorphisms in DNA repair genes, smoking, and bladder cancer
risk: findings from the international consortium of bladder cancer.
Cancer Res. 69:6857–6864. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zheng W, Cong XF, Cai WH, Yang S, Mao C
and Zou HW: Current evidences on XPC polymorphisms and breast
cancer susceptibility: a meta-analysis. Breast Cancer Res Treat.
128:811–815. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Liu C, Yin Q, Hu J, Li L, Zhang Y and Wang
Y: A meta-analysis of evidences on XPC polymorphisms and lung
cancer susceptibility. Tumor Biol. 34:1205–1213. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
D’Amelio AM, Monroy C, El-Zein R and Etzel
CJ: Using haplotype analysis to elucidate significant associations
between genes and Hodgkin lymphoma. Leuk Res. 36:1359–1364.
2012.PubMed/NCBI
|
|
35
|
Bai Y, Xu L, Yang X, et al: Sequence
variations in DNA repair gene XPC is associated with lung
cancer risk in a Chinese population: a case-control study. BMC
Cancer. 7:812007.PubMed/NCBI
|
|
36
|
Abbasi R, Ramroth H, Becher H, Dietz A,
Schmezer P and Popanda O: Laryngeal cancer risk associated with
smoking and alcohol consumption is modified by genetic
polymorphisms in ERCC5, ERCC6 and RAD23B but
not by polymorphisms in five other nucleotide excision repair
genes. Int J Cancer. 125:1431–1439. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Hussain SK, Mu LN, Cai L, et al: Genetic
variation in immune regulation and DNA repair pathways and stomach
cancer in China. Cancer Epidemiol Biomarkers Prev. 18:2304–2309.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Li Y, Gu S, Wu Q, et al: No association of
ERCC1 C8092A and T19007C polymorphisms to cancer risk: a
meta-analysis. Eur J Hum Genet. 15:967–973. 2007.
|
|
39
|
Shi TY, He J, Qiu LX, et al: Association
between XPF polymorphisms and cancer risk: a meta-analysis.
PLoS One. 7:e386062012.PubMed/NCBI
|
|
40
|
Zhang L, Wang J, Xu L, et al: Nucleotide
excision repair gene ERCC1 polymorphisms contribute to
cancer susceptibility: a meta-analysis. Mutagenesis. 27:67–76.
2012.
|
|
41
|
Zhu ML, Wang M, Cao ZG, et al: Association
between the ERCC5 Asp1104His polymorphism and cancer risk: a
meta-analysis. PLoS One. 7:e362932012.
|
|
42
|
Hung RJ, Christiani DC, Risch A, et al:
International Lung Cancer Consortium: pooled analysis of sequence
variants in DNA repair and cell cycle pathways. Cancer Epidemiol
Biomarkers Prev. 17:3081–3089. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Ding DP, He XF and Zhang Y: Lack of
association between XPG Asp1104His and XPF Arg415Gln polymorphism
and breast cancer risk: a meta-analysis of case-control studies.
Breast Cancer Res Treat. 129:203–209. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Jeon S, Choi JY, Lee KM, et al: Combined
genetic effect of CDK7 and ESR1 polymorphisms on
breast cancer. Breast Cancer Res Treat. 121:737–742. 2010.
|
|
45
|
Wheless L, Kistner-Griffin E, Jorgensen
TJ, et al: A community-based study of nucleotide excision repair
polymorphisms in relation to the risk of non-melanoma skin cancer.
J Invest Dermatol. 132:1354–1362. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Lolli G and Johnson LN:
CAK-cyclin-dependent activating kinase: a key kinase in cell cycle
control and a target for drugs? Cell Cycle. 4:572–577. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Melis JP, Luijten M, Mullenders LH and van
Steeg H: The role of XPC: implications in cancer and oxidative DNA
damage. Mutat Res. 728:107–117. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Chen Z, Yang J, Wang G, Song B, Li J and
Xu Z: Attenuated expression of xeroderma pigmentosum group C is
associated with critical events in human bladder cancer
carcinogenesis and progression. Cancer Res. 67:4578–4585. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Hadj-Rabia S, Oriot D, Soufir N, et al:
Unexpected extradermatological findings in 31 patients with
xeroderma pigmentosum type C. Br J Dermatol. 168:1109–1113. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Ito S, Kuraoka I, Chymkowitch P, et al:
XPG stabilizes TFIIH, allowing transactivation of nuclear
receptors: implications for Cockayne syndrome in XP-G/CS patients.
Mol Cell. 26:231–243. 2007. View Article : Google Scholar : PubMed/NCBI
|
